Mutations in the GlyT2 Gene (SLC6A5) Are a Second Major Cause of Startle Disease
Open accessThe DOI matches its Crossref record.
Abstract
Hereditary hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, leading to hypertonia and apnea episodes. Missense, nonsense, frameshift, splice site mutations, and large deletions in the human glycine receptor α1 subunit gene (GLRA1) are the major known cause of this disorder. However, mutations are also found in the genes encoding the glycine receptor β subunit (GLRB) and the presynaptic Na(+)/Cl(-)-dependent glycine transporter GlyT2 (SLC6A5). In this study, systematic DNA sequencing of SLC6A5 in 93 new unrelated human hyperekplexia patients revealed 20 sequence variants in 17 index cases presenting with homozygous or compound heterozygous recessive inheritance. Five apparently unrelated cases had the truncating mutation R439X. Genotype-phenotype analysis revealed a high rate of neonatal apneas and learning difficulties associated with SLC6A5 mutations. From the 20 SLC6A5 sequence variants, we investigated glycine uptake for 16 novel mutations, confirming that all were defective in glycine transport. Although the most common mechanism of disrupting GlyT2 function is protein truncation, new pathogenic mechanisms included splice site mutations and missense mutations affecting residues implicated in Cl(-) binding, conformational changes mediated by extracellular loop 4, and cation-π interactions. Detailed electrophysiology of mutation A275T revealed that this substitution results in a voltage-sensitive decrease in glycine transport caused by lower Na(+) affinity. This study firmly establishes the combination of missense, nonsense, frameshift, and splice site mutations in the GlyT2 gene as the second major cause of startle disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Amino acid transporters revisited: New views in health and disease
Kandasamy, P., Gyimesi, G., Kanai, Y., & Hediger, M. A. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.05.003 · Cited by 484
Asjad, H. M. M., Kasture, A., El-Kasaby, A., Sackel, M., Hummel, T., Freissmuth, M., & Sucic, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797092 · Cited by 53
SLC6 Transporter Folding Diseases and Pharmacochaperoning
Freissmuth, M., Stockner, T., & Sucic, S. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_71 · Cited by 42
Presynaptic control of inhibitory neurotransmitter content in VIAAT containing synaptic vesicles
Aubrey, K. R. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.002 · Cited by 30
Talvio, K., Minkeviciene, R., Townsley, K. G., Achuta, V. S., Huckins, L. M., Corcoran, P., Brennand, K. J., & Castrén, M. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1034679 · Cited by 5
“Many of these genes are associated with epilepsy and ictogenesis, including DPP10 , DOCK8 , IAH1 , LRRC4C, and SLC6A5 (Singh et al., 2006; Xiao et al., 2007; Carta et al., 2012; Wang et al., 2017; Parano et al., 2021).”
Influential
Metadata
- Authors
- Carta, E., Chung, S.-K., James, V. M., Robinson, A., Gill, J. L., Remy, N., Vanbellinghen, J.-F., Drew, C. J. G., Cagdas, S., Cameron, D., Cowan, F. M., Del Toro, M., Graham, G. E., Manzur, A. Y., Masri, A., Rivera, S., Scalais, E., Shiang, R., Sinclair, K., Stuart, C. A., Tijssen, M. A. J., Wise, G., Zuberi, S. M., Harvey, K., Pearce, B. R., Topf, M., Thomas, R. H., Supplisson, S., Rees, M. I., & Harvey, R. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 287
- Issue
- 34
- Pages
- 28975-28985
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2135835560
- Cited by
- 84
- References
- 0
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.